Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Interest Expenses: 2009-2024

Historic Interest Expenses for Lifecore Biomedical (LFCR) over the last 15 years, with Nov 2024 value amounting to $4.6 million.

  • Lifecore Biomedical's Interest Expenses rose 42.64% to $4.6 million in Q4 2024 from the same period last year, while for Nov 2024 it was $17.3 million, marking a year-over-year increase of 3.12%. This contributed to the annual value of $14.7 million for FY2024, which is 14.90% down from last year.
  • Per Lifecore Biomedical's latest filing, its Interest Expenses stood at $4.6 million for Q4 2024, which was up 5.07% from $4.4 million recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical's Interest Expenses ranged from a high of $6.1 million in Q3 2021 and a low of -$1.8 million during Q2 2020.
  • Moreover, its 3-year median value for Interest Expenses was $3.6 million (2022), whereas its average is $3.8 million.
  • Per our database at Business Quant, Lifecore Biomedical's Interest Expenses tumbled by 192.53% in 2020 and then skyrocketed by 271.92% in 2021.
  • Over the past 5 years, Lifecore Biomedical's Interest Expenses (Quarterly) stood at $1.6 million in 2020, then surged by 73.37% to $2.8 million in 2021, then skyrocketed by 30.39% to $3.6 million in 2022, then declined by 10.17% to $3.2 million in 2023, then skyrocketed by 42.64% to $4.6 million in 2024.
  • Its Interest Expenses stands at $4.6 million for Q4 2024, versus $4.4 million for Q3 2024 and $4.9 million for Q2 2024.